Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.96845 | 65 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.8084 | 64 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.80832 | 64 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.61363 | 61 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.70014 | 63 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.06397 | 67 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.1521 | 67 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.80518 | 64 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.72142 | 62 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.711 | 62 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.80635 | 64 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.69019 | 62 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.93192 | 65 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.80717 | 64 |